drugset / Trial / NCT02087202

Hyperalgesia and NMDA Receptor Antagonist

NCT02087202 ↗

RandomizedParallel-groupQuadruple-blindPrevention

Summary

NMDA receptor is administered and postoperative remote hyperalgesia is investigated.

Timeline

Start
2014-03
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule — —
Subject Magnesium Sulfate Other / unclassified — —

Indications

No indication recorded.